Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer.
Baggerly
Keith A
KA
Coombes
Kevin R
KR
Neeley
E Shannon
ES
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D023281:Genomics; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D011379:Prognosis
D000970:Antineoplastic Agents